CSF-1 as a regulator of macrophage activation and immune responses

Archivum Immunologiae et Therapiae Experimentalis

Volumn 51, Issue 3, 2003, Pages 169-177

  Sweet, Matthew J ^a   Hume, David A ^a  

^a NONE

Author keywords

CSF 1; Inflammation; Lipopolysaccharide; Macrophage; Toll like receptors

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA;

CELL DIFFERENTIATION; CELL GROWTH; CELL SURVIVAL; CYTOKINE PRODUCTION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATORY DISEASE; MACROPHAGE ACTIVATION; MONOCYTE; NONHUMAN; OSTEOCLAST; REVIEW;

EID: 0038687554     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (102)

1. ABD A. H., SAVAGE N. W., HALLIDAY W. J. and HUME D. A. (1991): The role of macrophages in experimental arthritis induced by Streptococcus agalactiae sonicate: actions of macrophage colony-stimulating factor (CSF-1) and other macrophage-modulating agents. Lymphokine Cytokine Res., 10, 43-50.
2. ALLEN W. E., JONES G. E., POLLARD J. W. and RIDLEY A. J. (1997): Rho, Rac and Cdc42 regulate actin organization and cell adhesion in macrophages. J. Cell Sci., 110, 707-720.
3. ASAKURA E., HANAMURA T., UMEMURA A., YADA K., YAMAUCHI T. and TANABE T. (1996): Effects of macrophage colony-stimulating factor (M-CSF) on lipopolysaccharide (LPS)-induced mediator production from monocytes in vitro. Immunobiology, 195, 300-313.
4. BAKER A. H., RIDGE S. A., HOY T., CACHIA P. G., CULLIGAN D., BAINES P., WHITTAKER J. A., JACOBS A. and PADUA R. A. (1993): Expression of the colony-stimulating factor 1 receptor in B lymphocytes. Oncogene, 8, 371-378.
5. BARTOCCI A., POLLARD J. W. and STANLEY E. R. (1986): Regulation of colony-stimulating factor 1 during pregnancy. J. Exp. Med., 164, 956-961.
6. BELOSEVIC M., DAVIS C. E., MELTZER M. S. and NACY C. A. (1988): Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-γ for induction of resistance to infection. J. Immunol., 141, 890-896.
7. BERGAMINI A., PERNO C. F., DINI L., CAPOZZI M., PESCE C. D., VENTURA L., CAPPANNOLI L., FALASCA L., MILANESE G., CALIO R. and ROCCHI G. (1994): Macrophage colony-stimulating factor enhances the susceptibility of macrophages to infection by human immunodeficiency virus and reduces the activity of compounds that inhibit virus binding. Blood, 84, 3405-3412.
8. BERNIER T., HALTER R., PAU D., RITTINGHAUSEN S. and EMMENDORFFER A. (2001): M-CSF transgenic mice: role of M-CSF in infection and autoimmunity. Exp. Toxicol. Pathol., 53, 165-173.
9. BISCHOF R. J., ZAFIROPOULOS D., HAMILTON J. A. and CAMPBELL I. K. (2000): Exacerbation of acute inflammatory arthritis by the colony-stimulating factors (CSF)-1 and granulocyte macrophage (GM)-CSF: evidence of macrophage infiltration and local proliferation. Clin. Exp. Immunol., 119, 361-367.
10. BLOOM R. D., FLORQUIN S., SINGER G. G., BRENNAN D. C. and KELLEY V. R. (1993): Colony-stimulating factor-1 in the induction of lupus nephritis. Kidney Int., 43, 1000-1009.
11. BOOCOCK C. A., JONES G. E., STANLEY E. R. and POLLARD J. W. (1989): Colony-stimulating factor-1 induces rapid behavioural responses in the mouse macrophage cell line, BAC1.2F5. J. Cell Sci., 93, 447-456.
12. CAMPBELL I. K., RICH M. J., BISCHOF R. J. and HAMILTON J. A. (2000): The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J. Leukoc. Biol., 68, 144-150.
13. CECCHINI M. G., DOMINGUEZ M. G., MOCCI S., WETTERWALD A., FELIX R., FLEISCH H., CHISHOLM O., HOFSTETTER W., POLLARD J. W. and STANLEY E. R. (1994): Role of colony-stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development, 120, 1357-1372.
14. CENCI E., BARTOCCI A., PUCCETTI P., MOCCI S., STANLEY E. R. and BISTONI F. (1991): Macrophage colony-stimulating factor in murine candidiasis: serum and tissue levels during infection and protective effect of exogenous administration. Infect. Immun., 59, 868-872.
15. CHEERS C. and STANLEY E. R. (1988): Macrophage production during murine listeriosis: colony-stimulating factor 1 (CSF-1) and CSF-1-binding cells in genetically resistant and susceptible mice. Infect. Immun., 56, 2972-2978.
16. CHEERS C., HILL M., HAIGH A. M. and STANLEY E. R. (1989): Stimulation of macrophage phagocytic but not bactericidal activity by colony-stimulating factor 1. Infect. Immun., 57, 1512-1516.
17. COSTELLOE E. O., STACEY K. J., ANTALIS T. M. and HUME D. A. (1999): Regulation of the plasminogen activator inhibitor-2 (PAI-2) gene in murine macrophages. Demonstration of a novel pattern of responsiveness to bacterial endotoxin. J. Leukoc. Biol., 66, 172-182.
18. DAI X. M., RYAN G. R., HAPEL A. J., DOMINGUEZ M. G., RUSSELL R. G., KAPP S., SYLVESTRE V. and STANLEY E. R. (2002): Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood, 99, 111-120.
19. DENIS M. (1991): Killing of Mycobacterium tuberculosis within human monocytes: activation by cytokines and calcitriol. Clin. Exp. Immunol., 84, 200-206.
20. DENIS M. and GREGG E. O. (1991): Identification of cytokines which enhance (CSF-1, IL-3) or restrict (IFN-γ) growth of intramacrophage Listeria monocytogenes. Immunol. Lett., 27, 237-242.
21. DEY A., SHE H., KIM L., BORUCH A., GURIS D. L., CARLBERG K., SEBTI S. M., WOODLEY D. T., IMAMOTO A. and LI W. (2000): Colony-stimulating factor-1 receptor utilizes multiple signaling pathways to induce cyclin D2 expression. Mol. Biol. Cell, 11, 3835-3848.
22. DOYLE A. G., HALLIDAY W. J., BARNETT C. J., DUNN T. L. and HUME D. A. (1992): Effect of recombinant human macrophage colony-stimulating factor 1 on immunopathology of experimental brucellosis in mice. Infect. Immun., 60, 1465-1472.
23. ENGELHARDT R., MACKENSEN A. and GALANOS C. (1991): Phase I trial of intravenously administered endotoxin (Salmonella abortus equi) in cancer patients. Cancer Res., 51, 2524-2530.
24. EVANS R., KAMDAR S. J., DUFFY T. M. and FULLER J. (1992): Synergistic interaction of bacterial lipopolysaccharide and the monocyte-macrophage colony-stimulating factor: potential quantitative and qualitative changes in macrophage-produced cytokine bioactivity. J. Leukoc. Biol., 51, 93-96.
25. EVANS R., KAMDAR S. J., FULLER J. A. and KRUPKE D. M. (1995): The potential role of the macrophage colony-stimulating factor 1, CSF-1, in inflammatory responses: characterization of macrophage cytokine gene expression. J. Leukoc. Biol., 58, 99-107.
26. EVANS R., SHULTZ L. D., DRANOFF G., FULLER J. A. and KAMDAR S. J. (1998): CSF-1 regulation of IL-6 gene expression by murine macrophages: a pivotal role for GM-CSF. J. Leukoc. Biol., 64, 810-816.
27. FIRESTEIN G. S., XU W. D., TOWNSEND K., BROIDE D., ALVARO-GRACIA J., GLASEBROOK A. and ZVAIFLER N. J. (1988): Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis. J. Exp. Med., 168, 1573-1586.
28. FOWLES L. F., MARTIN M. L., NELSEN L., STACEY K. J., REDD D., CLARK Y. M., NAGAMINE Y., McMAHON M., HUME D. A. and OSTROWSKI M. C. (1998): Persistent activation of mitogen-activated protein kinases p42 and p44 and ets-2 phosphorylation in response to colony-stimulating factor 1/c-fms signaling. Mol. Cell Biol., 18, 5148-5156.
29. FRANCOIS B., TRIMOREAU F., VIGNON P., FIXE P., PRALORAN V. and GASTINNE H. (1997): Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am. J. Med., 103, 114-120.
30. GALLO P., DE ROSSI A., SIVIERI S., CHIECO-BIANCHI L. and TAVOLATO B. (1994): M-CSF production by HIV-1-infected monocytes and its intrathecal synthesis. Implications for neurological HIV-1-related disease. J. Neuroimmunol., 51, 193-198.
31. GREGORY S. H. and WING E. J. (1993): Macrophage colony-stimulating factor and the enhanced migration of monocytes are essential in primary but not secondary host defenses to Listeria organisms. J. Infect. Dis., 168, 934-942.
32. GREGORY S. H., WING E. J., TWEARDY D. J., SHADDUCK R. K. and LIN H. S. (1992): Primary listerial infections are exacerbated in mice administered neutralizing antibody to macrophage colony-stimulating factor. J. Immunol., 149, 188-193.
33. GRUBER M. F., WEIH K. A., BOONE E. J., SMITH P. D. and CLOUSE K. A. (1995): Endogenous macrophage CSF production is associated with viral replication in HIV-1-infected human monocyte-derived macrophages. J. Immunol., 154, 5528-5535.
34. HALLET M. M., PRALORAN V., VIE H., PEYRAT M. A., WONG G., WITEK-GIANNOTFI J., SOULILLOU J. P. and MOREAU J. F. (1991): Macrophage colony-stimulating factor 1 (CSF-1) gene expression in human T-lymphocyte clones. Blood, 77, 780-786.
35. HAMILTON J. A. (1997): CSF-1 signal transduction: what is of functional significance? Immunol. Today, 18, 313-317.
36. HAMILTON J. A., WHITTY G. A., STANTON H. and MEAGER A. (1993): Effects of macrophage colony-stimulating factor on human monocytes: induction of expression of urokinase-type plasminogen activator, but not of secreted prostaglandin E2, interleukin-6, interleukin-1, or tumor necrosis factor-α. J. Leukoc. Biol., 53, 707-714.
37. HAMILTON J. A., WHITTY G. A., STANTON H., WOJTA J., GALLICHIO M., McGRATH K. and IANCHES G. (1993): Macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor stimulate the synthesis of plasminogen-activator inhibitors by human monocytes. Blood, 82, 3616-3621.
38. HASHIMOTO S., YODA M., YAMADA M., YANAI N., KAWASHIMA T. and MOTOYOSHI K. (1996): Macrophage colony-stimulating factor induces interleukin-8 production in human monocytes. Exp. Hematol., 24, 123-128.
39. HAYES M. P., WANG J. and NORCROSS M. A. (1995): Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-γ of lipopolysaccharide-inducible p35 and p40 genes. Blood, 86, 646-650.
40. HO J. L., REED S. G., WICK E. A. and GIORDANO M. (1990): Granulocyte-macrophage and macrophage colony-stimulating factors activate intramacrophage killing of Leishmania mexicana amazonensis. J. Infect. Dis., 162, 224-230.
41. HUME D. A., PAVLI P., DONAHUE R. E. and FIDLER I. J. (1988): The effect of human recombinant macrophage colony-stimulating factor 1 (CSF-1) on the murine mononuclear phagocyte system in vivo. J. Immunol., 141, 3405-3409.
42. ISBEL N. M., NIKOLIC-PATERSON D. J., HILL P. A., DOWLING J. and ATKINS R. C. (2001): Local macrophage proliferation correlates with increased renal M-CSF expression in human glomerulonephritis. Nephrol. Dial. Transplant, 16, 1638-1647.
43. JESSUP W., SQUIRES B., KRITHARIDES L., HUME D. A. and DEAN R. T. (1997): Effects of CSF-1 on cholesterol accumulation and efflux by macrophages. Arterioscler. Thromb. Vasc. Biol., 17, 18-25.
44. KALTER D. C., NAKAMURA M., TURPIN J. A., BACA L. M., HOOVER D. L., DIEFFENBACH C., RALPH P., GENDELMAN H. E. and MELTZER M. S. (1991): Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes. J. Immunol., 146, 298-306.
45. KAMDAR S. J., CHAPOVAL A. I., PHELPS J., FULLER J. A. and EVANS R. (1996): Differential sensitivity of mouse mononuclear phagocytes to CSF-1 and LPS: the potential in vivo relevance of enhanced IL-6 gene expression. Cell. Immunol., 174, 165-172.
46. KAMDAR S. J., FULLER J. A., NISHIKAWA S. I. and EVANS R. (1997): Priming of mouse macrophages with the macrophage colony-stimulating factor 1 (CSF-1) induces a variety of pathways that regulate expression of the interleukin 6 (IL-6) and granulocyte-macrophage colony-stimulating factor (Csfgm) genes. Exp. Cell Res., 235, 108-116.
47. KARBASSI A., BECKER J. M., FOSTER J. S. and MOORE R. N. (1987): Enhanced killing of Candida albicans by murine macrophages treated with macrophage colony-stimulating factor: evidence for augmented expression of mannose receptors. J. Immunol., 139, 417-421.
48. + blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum., 46, 2578-2586.
49. KAYASHIMA S., TSURU S., SHINOMIYA N., KATSURA Y., MOTOYOSHI K., ROKUTANDA M. and NAGATA N. (1991): Effects of macrophage colony-stimulating factor on reduction of viable bacteria and survival of mice during Listeria monocytogenes infection: characteristics of monocyte subpopulations. Infect. Immun., 59, 4677-4680.
50. KIM J. J., YANG J. S., LEE D. J., WILSON D. M., NOTTINGHAM L. K., MORRISON L., TSAI A., OH J., DANG K., DENTCHEV T., AGADJANYAN M. G., SIN J. I., CHALIAN A. A. and WEINER D. B. (2000): Macrophage colony-stimulating factor can modulate immune responses and attract dendritic cells in vivo. Hum. Gene Ther., 11, 305-321.
51. KREMLEV S. G., CHAPOVAL A. I. and EVANS R. (1998): CSF-1 (M-CSF) enhances the inflammatory response of fibronectin-primed macrophages: pathways involved in activation of the cytokine network. Nat. Immun., 16, 228-243.
52. KREMLEV S. G., CHAPOVAL A. I. and EVANS R. (1998): Cytokine release by macrophages after interacting with CSF-1 and extracellular matrix proteins: characteristics of a mouse model of inflammatory responses in vitro. Cell. Immunol., 185, 59-64.
53. KUTZA J., CRIM L., FELDMAN S., HAYES M. P., GRUBER M., BEELER J. and CLOUSE K. A. (2000): Macrophage colony-stimulating factor antagonists inhibit replication of HIV-1 in human macrophages. J. Immunol., 164, 4955-4960.
54. LE MEUR Y., TESCH G. H., HILL P. A., MU W., FOTI R., NIKOLIC-PATERSON D. J. and ATKINS R. C. (2002): Macrophage accumulation at a site of renal inflammation is dependent on the M-CSF/c-fms pathway. J. Leukoc. Biol., 72, 530-537.
55. LEE M. T. and WARREN M. K. (1987): CSF-1-induced resistance to viral infection in murine macrophages. J. Immunol., 138, 3019-3022.
56. MA X., GRI G. and TRINCHIERI G. (1996): A novel Ets-2-related nuclear factor is involved in transcriptional activation of the human interleukin-12 p40 gene promoter in response to interferon-γ and LPS stimulation of monocytic cells. Ann. N. Y. Acad. Sci., 795, 357-360.
57. MA X., NEURATH M., GRI G. and TRINCHIERi G. (1997): Identification and characterization of a novel Ets-2-related nuclear complex implicated in the activation of the human interleukin-12 p40 gene promoter. J. Biol. Chem., 272, 10389-10395.
58. MATSUDA M., SHIKATA K., WADA J., YAMAJI H., SHIKATA Y., DOI A., KOSAKA M., AKAGI H., MASUDA Y., OHMOTO Y. and MAKINO H. (1999): Increased urinary excretion of macrophage colony-stimulating factor (M-CSF) in patients with IgA nephropathy: tonsil stimulation enhances urinary M-CSF excretion. Nephron, 81, 264-270.
59. MATSUZAWA K., YOO Y. C., FUKUSHIMA A., YOSHIMATSU K., ARIKAWA J. and AZUMA I. (1997): Protective effect of mucosal administration of recombinant human macrophage colony-stimulating factor (rhM-CSF) on mucosal infection of Sendai virus in mice. Vaccine, 15, 85-89.
60. Moss M. L., JIN S. L., BECHERER J. D., BICKETT D. M., BURKHART W., CHEN W. J., HASSLER D., LEESNITZER M. T., McGEEHAN G., MILLA M., MOYER M., ROCQUE W., SEATON T., SCHOENEN F., WARNER J. and WILLARD D. (1997): Structural features and biochemical properties of TNF-α converting enzyme (TACE). J. Neuroimmunol., 72, 127-129.
61. Moss M. L., JIN S. L., MILLA M. E., BICKETT D. M., BURKHART W., CARTER H. L., CHEN W. J., CLAY W. C., DIDSBURY J. R., HASSLER D., HOFFMAN C. R., KOST T. A., LAMBERT M. H., LEESNITZER M. A., McCAULEY P., McGEEHAN G., MITCHELL J., MOYER M., PAHEL G., ROCQUE W., OVERTON L. K., SCHOENEN F., SEATON T., SU J. L., WARNER J., WILLARD D. and BECHERER J. D. (1997): Cloning of a disintegrin metalloproteinase that processes precursor tumour necrosis factor-α. Nature, 385, 733-736.
62. MUNN D. H. and ARMSTRONG E. (1993): Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by γ-interferon. Cancer Res., 53, 2603-2613.
63. MUNN D. H., PRESSEY J., BEALL A. C., HUDES R. and ALDERSON M. R. (1996): Selective activation-induced apoptosis of peripheral T cells imposed by macrophages. A potential mechanism of antigen-specific peripheral lymphocyte deletion. J. Immunol., 156, 523-532.
64. MUNN D. H., SHAFIZADEH E., ATTWOOD J. T., BONDAREV I., PASHINE A. and MELLOR A. L. (1999): Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med., 189, 1363-1372.
65. MUNN D. H., ZHOU M., ATTWOOD J. T., BONDAREV I., CONWAY S. J., MARSHALL B., BROWN C. and MELLOR A. L. (1998): Prevention of allogeneic fetal rejection by tryptophan catabolism. Science, 281, 1191-1193.
66. NAKOINZ I. and RALPH P. (1988): Stimulation of macrophage antibody-dependent killing of tumor targets by recombinant lymphokine factors and M-CSF. Cell. Immunol., 116, 331-340.
67. NIKOLIC-PATERSON D. J., LAN H. Y. and ATKINS R. C. (2001): Macrophages in immune renal injury. In NEILSON E. G. and COUSER W. G. (eds.): Immunologic renal disease. Raven Press, New York, 609-632.
68. OHTSUKI T., Suzu S., HATAKE K., NAGATA N., MIURA Y. and MOTOYOSHI K. (1993): A proteoglycan form of macrophage colony-stimulating factor that binds to bone-derived collagens and can be extracted from bone matrix. Biochem. Biophys. Res. Commun., 190, 215-222.
69. OZINSKY A., UNDERHILL D. M., FONTENOT J. D., HAJJAR A. M., SMITH K. D., WILSON C. B., SCHROEDER L. and ADEREM A. (2000): The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl. Acad. Sci. USA, 97, 13766-13771.
70. PHILLIPS W. A. and HAMILTON J. A. (1990): Colony-stimulating factor-1 is a negative regulator of the macrophage respiratory burst. J. Cell. Physiol., 144, 190-196.
71. PIERCE J. H., DI MARCO E., COX G. W., LOMBARDI D., RUGGIERO M., VARESIO L., WANG L. M., CHOUDHURY G. G., SAKAGUCHI A. Y., DI FIORE P. P. and AARONSON S. A. (1990): Macrophage colony-stimulating factor 1 (CSF-1) induces proliferation, chemotaxis, and reversible monocytic differentiation in myeloid progenitor cells transfected with the human c-fms/CSF-1 receptor cDNA. Proc. Natl. Acad. Sci. USA, 87, 5613-5617.
72. PRALORAN V., GASCAN H., PAPIN S., CHEVALIER S., TROSSAERT M. and BOURSIER M. C. (1990): Inducible production of macrophage colony-stimulating factor 1 (CSF-1) by malignant and normal human T cells. Leukemia, 4, 411-414.
73. PRICE L. K., CHOI H. U., ROSENBERG L. and STANLEY E. R. (1992): The predominant form of secreted colony-stimulating factor-1 is a proteoglycan. J. Biol. Chem., 267, 2190-2199.
74. ROILIDES E., SEIN T., HOLMES A., CHANOCK S., BLAKE C., PIZZO P. A. and WALSH T. J. (1995): Effects of macrophage colony-stimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J. Infect. Dis., 172, 1028-1034.
75. ROTH P., BARTOCCI A. and STANLEY E. R. (1997): Lipopolysaccharide induces synthesis of mouse colony-stimulating factor 1 in vivo. J. Immunol., 158, 3874-3880.
76. ROTH P. and STANLEY E. R. (1992): The biology of CSF-1 and its receptor. Curr. Top. Microbiol. Immunol., 181, 141-167.
77. RYAN G. R., DAI X. M., DOMIGUEZ M. G., TONG W., CHUAN F., CHISHOLM O., RUSSELL R. G., POLLARD J. W. and STANLEY E. R. (2001): Rescue of the colony-stimulating factor 1 (CSF-1)-nullizygous mouse (Csf1(op)/Csf1(op)) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis. Blood, 98, 74-84.
78. + blood monocytes in patients with chronic renal failure undergoing dialysis: possible involvement of macrophage colony-stimulating factor. Acta. Haematol., 105, 21-26.
79. SAKURAI T., WAKIMOTO N., YAMADA M., SHIMAMURA S. and MOTOYOSHI K. (1998): Effect of macrophage colony-stimulating factor (M-CSF) on mouse immune responses in vivo. Immunopharmacol. Immunotoxicol., 20, 79-102.
80. SAMPSON-JOHANNES A. and CARLINO J. A. (1988): Enhancement of human monocyte tumoricidal activity by recombinant M-CSF. J. Immunol., 141, 3680-3686.
81. SELTZ M., LOETSCHER P., FEY M. F. and TOBLER A. (1994): Constitutive mRNA and protein production of macrophage colony-stimulating factor but not of other cytokines by synovial fibroblasts from rheumatoid arthritis and osteoarthritis patients. Br. J. Rheumatol., 33, 613-619.
82. SHIMA M., TEITELBAUM S. L., HOLERS V. M., RUZICKA C., OSMACK P. and Ross F. P. (1995): Macrophage colony-stimulating factor regulates expression of the integrins α4β1 and α5β1 by murine bone marrow macrophages. Proc. Natl. Acad. Sci. USA, 92, 5179-5183.
83. STACEY K. J., FOWLES L. F., COLMAN M. S., OSTROWSKI M. C. and HUME D. A. (1995): Regulation of urokinase-type plasminogen activator gene transcription by macrophage colony-stimulating factor. Mol. Cell. Biol., 15, 3430-3441.
84. STANLEY E. R., BERG K. L., EINSTEIN D. B., LEE P. S., PIXLEY F. J., WANG Y. and YEUNG Y. G. (1997): Biology and action of colony-stimulating factor-1. Mol. Reprod. Dev., 46, 4-10.
85. STROCKBINE L. D., COHEN J. I., FARRAH T., LYMAN S. D., WAGENER F., DUBOSE R. F., ARMITAGE R. J. and SPRIGGS M. K. (1998): The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J. Virol., 72, 4015-4021.
86. SWEET M. J., CAMPBELL C. C., SESTER D. P., XU D., McDONALD R. C., STACEY K. J., HUME D. A. and LIEW F. Y. (2002): Colony-stimulating factor-1 suppresses responses to CpG DNA and expression of Toll-like receptor 9 but enhances responses to lipopolysaccharide in murine macrophages. J. Immunol., 168, 392-399.
87. SZPERL M., ANSARI A. A., URBANOWSKA E., SZWECH P., KALINSKI P. and WIKTOR-JEDRZEJCZAK W. (1995): Increased resistance of CSF-1-deficient, macrophage-deficient, TNF-α-deficient, and IL-1α-deficient op/op mice to endotoxin. Ann. N.Y. Acad. Sci., 762, 499-501.
88. TAKAHASHI M., HONG Y. M., YASUDA S., TAKANO M., KAWAI K., NAKAI S. and HIRAI Y. (1988): Macrophage colony-stimulating factor is produced by human T lymphoblastoid cell line, CEM-ON: identification by amino-terminal amino acid sequence analysis. Biochem. Biophys. Res. Commun., 152, 1401-1409.
89. TAKEDA K., KAISHO T. and AKIRA S. (2003): Toll-like receptors. Annu. Rev. Immunol., 21, 335-376.
90. TERANISHI A., AKADA S., SAITO S., HATAKE K. and MORIKAWA H. (2002): Macrophage colony-stimulating factor restored chemotherapy-induced granulocyte dysfunctions: role of IL-8 production by monocytes. Int. Immunopharmacol., 2, 83-94.
91. TILL K. J., LOPEZ A., SLUPSKY J. and CAWLEY J. C. (1993): C-fms protein expression by B-cells, with particular reference to the hairy cells of hairy-cell leukaemia. Br. J. Haematol., 83, 223-231.
92. TOJO N., ASAKURA E., KOYAMA M., TANABE T. and NAKAMURA N. (1999): Effects of macrophage colony-stimulating factor (M-CSF) on protease production from monocyte, macrophage and foam cell in vitro: a possible mechanism for anti-atherosclerotic effect of M-CSF. Biochim. Biophys. Acta., 1452, 275-284.
93. UTSUNOMIYA Y., OMURA K., YOKOO T., IMASAWA T., KAWAMURA T., ABE A., HIRANO K., MITARAI T., MARUYAMA N. and SAKAI O. (1996): Macrophage colony-stimulating factor (M-CSF) enhances proteinuria and recruitment of macrophages into the glomerulus in experimental murine nephritis. Clin. Exp. Immunol., 106, 286-296.
94. VASSILIADIS S. and ATHANASSAKIS I. (1994): Two novel colony-stimulating factor-1 (CSF-1) properties: it post-transcriptionally inhibits interferon-specific induction of class II antigens and reduces the risk of fetal abortion. Cytokine, 6, 295-299.
95. WALKER T. M., BURGER C. J. and ELGERT K. D. (1993): Tumor growth alters macrophage responsiveness to macrophage colony-stimulating factor during reactivity against allogeneic and syngeneic MHC class II molecules. Immunol. Invest., 22, 463-476.
96. WANG J. M., GRIFFIN J. D., RAMBALDI A., CHEN Z. G. and MANTOVANI A. (1988): Induction of monocyte migration by recombinant macrophage colony-stimulating factor. J. Immunol., 141, 575-579.
97. WANG J., RODERIQUEZ G., ORAVECZ T. and NORCROSS M. A. (1998): Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression. J. Virol., 72, 7642-7647.
98. WARREN M. K. and RALPH P. (1986): Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony-stimulating activity. J. Immunol., 137, 2281-2285.
99. WEBB S. E., POLLARD J. W. and JONES G. E. (1996): Direct observation and quantification of macrophage chemoattraction to the growth factor CSF-1. J. Cell Sci., 109, 793-803.
100. WIKTOR-JEDRZEJCZAK W., DZWIGALA B., SZPERL M., MARUSZYNSKI M., URBANOWSKA E. and SZWECH P. (1996): Colony-stimulating factor 1-dependent resident macrophages play a regulatory role in fighting Escherichia coli fecal peritonitis. Infect. Immun., 64, 1577-1581.
101. WOHLWEND A., BELIN D. and VASSALLI J. D. (1987): Plasminogen activator-specific inhibitors in mouse macrophages: in vivo and in vitro modulation of their synthesis and secretion. J. Immunol., 139, 1278-1284.
102. ZISMAN E., WAISMAN A., BEN-YAIR E. and TARTAKOVSKY B. (1993): Production of colony-stimulating factor 1 by T cells: possible involvement in their interaction with antigen-presenting cells. Cytokine, 5, 309-318.